虫子作为药物:寄生虫生物分子作为抗乳腺癌的新疗法
Said B Gonzalez1, Pushkar Shivam1, Destiny Ball1
1Department of Biomedical Sciences, School of Graduate Studies, Meharry Medical College, Nashville, TN, USA.
American journal of physiology. Cell physiology
|March 5, 2026
概括
寄生虫提供了具有抗瘤特性的新生物分子. 本综述探讨利用寄生虫诱导的炎症用于创新的乳腺癌疗法,可能作为当前治疗方法的替代品或添加剂.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 寄生虫学的寄生虫学
背景情况:
- 目前的乳腺癌治疗方法,如化疗,手术和放射治疗是侵入性的,并具有严重的副作用.
- 寄生虫,在治疗上使用了数千年,拥有独特的生物分子,具有免疫调节和抗瘤特性.
- 宿主对寄生虫感染的炎症反应为新型癌症疗法提供了潜在的途径.
研究的目的:
- 审查目前关于利用宿主对寄生虫感染的反应来治疗乳腺癌的知识.
- 为了确定寄生虫诱导的抗瘤效应背后的分子机制.
- 探索寄生虫生物分子作为乳腺癌治疗替代品或辅助剂的潜力.
主要方法:
- 关于寄生虫与宿主相互作用和癌症治疗现有研究的文献综述.
- 基于寄生虫诱导的免疫调节和抗瘤活性的分子机制的分析.
- 综合发现,提出乳腺癌的新疗法策略.
主要成果:
- 寄生虫拥有具有显著免疫调节和抗瘤潜力的生物分子.
- 宿主对寄生虫的炎症反应可以被利用用于抗癌效应.
- 了解寄生虫诱导的分子通路是开发新治疗方法的关键.
结论:
- 寄生虫衍生生物分子是新型乳腺癌治疗的有希望的来源.
- 利用寄生虫诱导的炎症提供了对抗乳腺癌的新策略.
- 对分子机制的进一步研究可能会导致基于寄生虫的有效癌症治疗.
相关概念视频
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Drugs that Stabilize Microtubules
2.8K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K


